Comments on EFSA opinions on Impossible Foods’ application for EU market approval of its soy leghemoglobin product derived from GM yeast K. phaffii: Major gaps and errors identified By Claire Robinson, Co-Director, GMWatch, and Michael Antoniou, Professor of Molecular Genetics and Toxicology, King’s College London*